DOI:
10.1055/s-00000034
Klinische Pädiatrie
Issue S1 ·
Volume 213 ·
September 2001
DOI: 10.1055/s-002-1188
A3
ORIGINALARBEIT
A5
Fleischhack, G.;
Simon, A.:
Importance of prevention of infectious complications in pediatric hematologic-oncologic patients
A9
Simon, A.;
Fleischhack, G.:
Non-pharmacologic strategies to prevent and control infectious complications in pediatric hematology/oncology patients
A22
Simon, A.;
Fleischhack, G.;
Marklein, G.;
Ritter, J.:
Antimicrobial prophylaxis of bacterial infections in pediatric oncology patients
A38
Groll, A. H.;
Ritter, J.;
Müller, F.-M. C.:
Guidelines for Prevention of Pneumocystis carinii Pneumonitis in Children and Adolescents with Cancer
A50
Groll, A. H.;
Ritter, J.;
Müller, F.-M. C.:
Prevention of Fungal Infections in Children and Adolescents with Cancer
A69
Graubner, U. B.:
Antiviral prophylaxis
A77
Graubner, U. B.;
Liese, J.;
Belohradsky, B. H.:
Vaccination
A84
Eber, S. W.;
Belohradsky, B. H.;
Weiß, M.:
Antiinfectious prophylaxis in asplenia
A88
Lehrnbecher, T.:
Hematopoietic growth factors in the prevention of infections complications in children with hematologic-oncologic diseases
A103
Lehrnbecher, T.:
Intravenous immunoglobulins in the prevention of infection in children with hematologic-oncologic diseases.
A106
Simon, A.;
Fleischhack, G.:
Surveillance for Nosocomial Infections in Pediatric Hematology/Oncology Patients